Back to resultsTreatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison
Primary Purpose
Attention Deficit Hyperactivity Disorder
Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Strattera
Sponsored by
About this trial
This is an interventional treatment trial for Attention Deficit Hyperactivity Disorder focused on measuring Attention Deficit Hyperactivity Disorder, treatment,, Strattera,, rehabilitation
Eligibility Criteria
Inclusion Criteria: All prisoners that fullfill the diagnostic criterias for ADHD - Exclusion Criteria: All other prisoners -
Sites / Locations
- St. Olavs Hospital. Departement for forensic psyciatry, Brøset.
Outcomes
Primary Outcome Measures
The symptoms of Attention Deficit Hyperactive Disorders and the prisoners use of the prisons rehabilitation services before and after treatment will be measured
Secondary Outcome Measures
Full Information
NCT ID
NCT00356070
First Posted
July 24, 2006
Last Updated
April 26, 2017
Sponsor
Norwegian University of Science and Technology
1. Study Identification
Unique Protocol Identification Number
NCT00356070
Brief Title
Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison
Official Title
Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison
Study Type
Interventional
2. Study Status
Record Verification Date
April 2017
Overall Recruitment Status
Completed
Study Start Date
January 2006 (Actual)
Primary Completion Date
December 2006 (Actual)
Study Completion Date
December 2006 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Norwegian University of Science and Technology
4. Oversight
5. Study Description
Brief Summary
The treatment of ADHD in jail will help the prisoners in their rehabilitation process
Detailed Description
Prisoners with ADHD will be offered treatment with Stratera, and we wanted to study their use of the prisons rehabilitation offers as school, programs and work training before and after treatment with Stratera.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Attention Deficit Hyperactivity Disorder
Keywords
Attention Deficit Hyperactivity Disorder, treatment,, Strattera,, rehabilitation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
40 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Strattera
Primary Outcome Measure Information:
Title
The symptoms of Attention Deficit Hyperactive Disorders and the prisoners use of the prisons rehabilitation services before and after treatment will be measured
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
All prisoners that fullfill the diagnostic criterias for ADHD -
Exclusion Criteria:
All other prisoners -
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Roger Almvik, md phd
Organizational Affiliation
St. Olavs Hospital, Departement of forensic psychiatry, Brøset
Official's Role
Principal Investigator
Facility Information:
Facility Name
St. Olavs Hospital. Departement for forensic psyciatry, Brøset.
City
Trondheim
ZIP/Postal Code
7040
Country
Norway
12. IPD Sharing Statement
Learn more about this trial
Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison
We'll reach out to this number within 24 hrs